Weiss Multi Strategy Advisers LLC Clovis Oncology, Inc. Call Options Transaction History

Weiss Multi Strategy Advisers LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$12.81 - $25.67 $192,150 - $385,050	-15,000 Reduced 60.0%	10,000 $149,000
Q1 2019 May 15, 2019	BUY	$17.66 - $30.28 $441,500 - $757,000	25,000 New	25,000 $621,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.